CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout
← All indications

Radiation Pneumonitis

Inflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.

Drugs by status

Phase 4 trials (2)

  • alteplase
  • dnase

Phase 2 trials (16)

  • urea
  • captopril
  • prednisone
  • enalapril
  • nintedanib
  • hl301
  • pirfenidone
  • endostatin
  • immune globulin (human)
  • proanthocyanidin extract
  • infliximab
  • budesonide
  • oxygen
  • nicorandil
  • cbp8
  • babaodan

Phase 1 trials (2)

  • fapi-46
  • phellinus igniarius

Other trials (2)

  • procaine benzylpenicillin
  • losartan

Organizations

Organization Involved with Phase 2 Indications (19)

  • Hanlim Pharm. Co., Ltd.
  • Shanghai Genomics, Inc.
  • Boehringer Ingelheim
  • National Cancer Institute (NCI)
  • University of London
  • Cornell University
  • Harvard University
  • Instituto Nacional de Enfermedades Respiratorias
  • NRG Oncology
  • Northwestern University
  • Radiation Therapy Oncology Group
  • Taipei Medical University
  • Royal Marsden Hospital NHS Trust
  • Government of Mexico
  • State University of New York, Buffalo
  • Department of Veteran Affairs
  • National Comprehensive Cancer Network
  • GNI Group
  • People's Liberation Army of China

Organization Involved with Other Experimental Indications (2)

  • National Institutes of Health (NIH)
  • University of South Florida

ICD-10 crosswalk

  • J70.0 — Acute pulmonary manifestations due to radiation

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.